Novel approaches are necessary as conventional methods have failed to avoid the ever-increasing incidence of hospital-acquired / healthcare-associated infections (HAIs). CHAIN Antimicrobials Ltd. is a biotech company that was set up to devise such novel approaches and develops improved technologies to enhance the safety of medical devices. The company was established as a spin-out from the University of Oulu, where R&D activities were carried out by the founders of the company. Our team of dedicated experts is involved in the design and development of potentially highly effective, antimicrobial coated catheters to prevent HAIs. At CHAIN Antimicrobials Oy, we have designed an effective solution to prevent catheter-associated urinary tract infections (CAUTIs). Our lead product peptide-coated catheters (PACs) are highly active antimicrobial peptides and have shown positive results in in-vitro studies. Preclinical trials are now underway to test efficacy in animal models.
Health & Life Science, Healthcare and Wellness services, Life Science, pharmaceutical
B2B, Health, R&D